| Bioactivity | N-6-Methyl-2-deoxyadenosine is an adenine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | |||||||||
| Name | N-6-Methyl-2-deoxyadenosine | |||||||||
| CAS | 2002-35-9 | |||||||||
| Formula | C11H15N5O3 | |||||||||
| Molar Mass | 265.27 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
N-6-Methyl-2-deoxyadenosine
CAS: 2002-35-9 F: C11H15N5O3 W: 265.27
N-6-Methyl-2-deoxyadenosine is an adenine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity t
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.